DeepSurgery raises nearly RMB 100 million Series B for FUNZAR, its third round in 15 months
Guangzhou DeepSurgery closed a Series B of nearly RMB 100 million co-led by Mifang Capital and Shengshi Investment. Its FUNZAR microsurgical robot has 16 degrees of freedom, entered China's innovative-device green channel in 2026, and is running registration trials at six hospitals.
1 min readSources verified